CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?

Seung Tae Kim, Won Jin Chang, Lihua Jin, Jae Sook Sung, Yun Ji Choi, Yeul Hong Kim

Cancer Research and Treatment. 2015;47(4):796-803. Published online 2015 January 30 DOI: https://doi.org/10.4143/crt.2014.106

Can Serum be Used for Analyzing the <i>KRAS</i> Mutation Status in Patients with Advanced Colorectal Cancer?

Seung Tae Kim, Won Jin Chang, Lihua Jin, Jae Sook Sung, Yun Ji Choi, Yeul Hong Kim

Cancer Research and Treatment. 2015;47(4):796-803

Link1

Link2 Link3

9136 POSTER Can Serum Be Used for Analyzing the EGFR Mutation Status in Patients With Advanced Non-Small Cell Cancer (NSCLC)?

S. Kim, H. Jung, J. Sung, U. Jo, Y. Kim, S. Shin, T. Tanaka, K. Hagiwara, Y. Choi

European Journal of Cancer. 2011;47:S634

Link1 Link2

To Give or Not to Give Anti–Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies to Patients With KRAS G13D Mutation in Advanced Colorectal Cancer

Richard Kim, Timothy Kubal

Clinical Colorectal Cancer. 2012;11(2):85-87

Link1 Link2

18 F-FDG uptake heterogeneity predicts KRAS/NRAS/BRAF mutation status in patients with liver metastases of colorectal cancer

Guang Ma, Fangsong Zhang, Qiufang Liu, Lingling Pan, Jianping Zhang, Yingjian Zhang, Shaoli Song

. 2020;

Link1 Link2

Letter to the Editor: Worse prognosis caused by anti-EGFR treatment in advanced colorectal cancer patients with KRAS mutation

Peihao Yin, Yanyan Qiu, Qi Li

International Journal of Colorectal Disease. 2012;28(5):733-734

Link1

Link2 Link3

Clinic-pathological characteristics of MMR protein, KRAS-NRAS-BRAF gene mutation, HER-2 and PD-L1 status in 3822 Chinese colorectal cancer patients

Li Zhang, Nan Chen, Zhongwu Li, Aiwen Wu, Jie Chen

. 2020;

Link1 Link2

KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal Cancer

Nirit Yarom, Gillian Gresham, Nana Boame, Derek Jonker

Clinical Colorectal Cancer. 2019;18(4):e309-e315

Link1 Link2

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients

Zhouhuan Dong, Linghong Kong, Zhiyi Wan, Fengwei Zhu, Mei Zhong, Yali Lv, Po Zhao, Huaiyin Shi

Scientific Reports. 2019;9(1):

Link1

Link2 Link3

KRAS Mutation Screening in Colorectal Cancer: From Paper to Practice

Marwan M. Fakih

Clinical Colorectal Cancer. 2010;9(1):22-30

Link1 Link2

Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases

Georgios A. Margonis, Yuhree Kim, Kazunari Sasaki, Mario Samaha, Neda Amini, Timothy M. Pawlik

Cancer. 2016;122(17):2698-2707

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.